123 related articles for article (PubMed ID: 370028)
21. Role of sialic acid in the macrophage glycolipid receptor for MIF.
Liu DY; Petschek KD; Remold HG; David JR
J Immunol; 1980 Apr; 124(4):2042-7. PubMed ID: 6988512
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of action of lymphokines. VII. Modulation of the action of macrophage migration inhibitory factor by antioxidants and drugs affecting thromboxane synthesis.
Jakubowski A; Pick E
Immunopharmacology; 1983 Oct; 6(3):215-29. PubMed ID: 6313550
[TBL] [Abstract][Full Text] [Related]
23. Macrophage migration inhibition factor (MIF): reducing the variables.
MacSween JM; Rajaraman K; Rajaraman R; Fox RA
J Immunol Methods; 1982; 52(1):127-36. PubMed ID: 6288804
[TBL] [Abstract][Full Text] [Related]
24. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
[TBL] [Abstract][Full Text] [Related]
25. Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.
Pick E
Immunology; 1974 Mar; 26(3):649-58. PubMed ID: 4369184
[TBL] [Abstract][Full Text] [Related]
26. 2-mercaptoethanol in vitro and macrophage migration in normal and sensitized guinea pigs.
Prokić LM; Vilić IM
Biomed Pharmacother; 1985; 39(6):330-4. PubMed ID: 3910130
[TBL] [Abstract][Full Text] [Related]
27. Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA.
Gordon MR; Chida K; Takata I; Myrvik QN
J Leukoc Biol; 1987 Sep; 42(3):197-203. PubMed ID: 3305746
[TBL] [Abstract][Full Text] [Related]
28. Macrophage activation induced by lymphocyte mediators.
David JR
Acta Endocrinol Suppl (Copenh); 1975; 194():245-61. PubMed ID: 1092116
[TBL] [Abstract][Full Text] [Related]
29. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
Balakrishnan K; Hanjan SN; Talwar JP
Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
[No Abstract] [Full Text] [Related]
30. The role of suppressor cells in the production of macrophage migration inhibition factor.
Fox RA; Rajaraman K
Immunol Commun; 1978; 7(3):311-21. PubMed ID: 350758
[TBL] [Abstract][Full Text] [Related]
31. Regulatory mechanisms of cutaneous delayed-type hypersensitivity. I. Suppression of cutaneous delayed-type hypersensitivity by migration inhibitory factor.
Mizushima A; Baba T; Ochiya T; Yamaguchi K; Onozaki K; Yaoita H; Uyeno K
Cell Immunol; 1983 Oct; 81(1):126-33. PubMed ID: 6352055
[TBL] [Abstract][Full Text] [Related]
32. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
Rocklin RE
J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
[No Abstract] [Full Text] [Related]
33. Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
Yoshida T; Bigazzi P; Cohen S
Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1641-4. PubMed ID: 165520
[TBL] [Abstract][Full Text] [Related]
34. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
Postlethwaite AE; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
[TBL] [Abstract][Full Text] [Related]
35. Assay of human lymphokines in vitro. Evidence for a migration stimulation factor (MStF) which interferes with the macrophage migration inhibition assay.
Aaskov JG; Anthony HM
Aust J Exp Biol Med Sci; 1976 Dec; 54(6):527-39. PubMed ID: 800335
[TBL] [Abstract][Full Text] [Related]
36. Colchicine down-regulates lipopolysaccharide-induced granulocyte-macrophage colony-stimulating factor production in murine macrophages.
Rao P; Falk LA; Dougherty SF; Sawada T; Pluznik DH
J Immunol; 1997 Oct; 159(7):3531-9. PubMed ID: 9317152
[TBL] [Abstract][Full Text] [Related]
37. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
[TBL] [Abstract][Full Text] [Related]
38. An ELISA method for quantitation of macrophage migration from agarose microdroplets.
Peck R
J Immunol Methods; 1983 Nov; 64(1-2):179-87. PubMed ID: 6358361
[TBL] [Abstract][Full Text] [Related]
39. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
Friedrich W; Lazary S; Geczy C; de Weck AL
Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
[TBL] [Abstract][Full Text] [Related]
40. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
